Colgate-Palmolive stock price jumps 6% after earnings; what CL investors watch next week
Colgate-Palmolive shares rose 6% to $90.29 Friday after fourth-quarter net sales climbed 5.8% to $5.23 billion, but GAAP earnings swung to a loss due to a $794 million skin-health impairment. The company’s 2026 outlook includes finalized tariffs and projects net sales growth of 2% to 6%. North America sales fell, while Latin America and Africa/Eurasia posted double-digit gains.